Cooperative Agreement UG3AT009761

The University of Texas Health Science Center of San Antonio will receive $3 million in cooperative agreement funding from the Department of the Army Medical Command to conduct a randomized clinical trial combining stellate ganglion block with prolonged exposure therapy for post-traumatic stress disorder (PTSD). The four-year award under the Military Medical Research and Development program (CFDA 12.420) aims to investigate medical solutions for traumatic battlefield injuries and transform...

Federal Grant Award Summary The Veterans Medical Research Foundation of San Diego received a $4.8 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with completion targeted for August 31, 2029. This award funds a hybrid Type I evaluation of integrative health care interventions for Post-Traumatic Stress Disorder (PTSD), combining rigorous clinical trial methodology with implementation...

This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will provide $332,716.00 to Michigan State University to assess the feasibility of implementing manual medicine techniques in the multimodal management of chronic low back pain among veterans and service members. The research, which will be conducted from November 1, 2024, to October 31, 2026, aims to explore innovative approaches to...

This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $6,964,861.00 to The University of Texas Health Science Center at San Antonio to conduct a multi-year longitudinal study focused on military psychological health. The study has five specific aims: Conduct a prospective, longitudinal follow-up of 3,360 previous clinical trial participants treated for PTSD, sleep disorders, or chronic pain. Conduct a...

This federal Project Grant award of $2,398,281.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program aims to increase access to evidence-based PTSD treatment for military service members and veterans through Behavioral Health Technician-delivered Written Exposure Therapy (WET). The primary awardee, Palo Alto Veterans Institute for Research (Pavir), will oversee the overall project objectives, which include providing WET training to...

This $2.9 million Defense Health Agency project grant funds research on suicide prevention among military personnel and veterans. The grant supports a multi-site randomized clinical trial through September 2026 to evaluate the efficacy of Written Exposure Therapy for Suicide Prevention compared to treatment as usual. Researchers at Boston University and partner institutions University of Colorado Denver and University of Texas Health Science Center San Antonio aim to reduce suicidal thoughts and...

Federal Project Grant Award Summary The Defense Health Agency awarded Western Institute For Veterans Research $4,613,247 through the Military Medical Research and Development program (CFDA 12.420) on September 1, 2025, to conduct research on photobiomodulation treatment for chronic traumatic brain injury (TBI) in service members, veterans, and first responders. The project, "Shining Light on Trauma: Treatment of Chronic TBI to Improve Psychological Health Using Photobiomodulation in Service...

Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $2.48M to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, to conduct a Phase 2A randomized controlled clinical trial evaluating the efficacy and safety of PT150 in treating posttraumatic stress disorder (PTSD) in U.S. military veterans. The four-year project, scheduled for completion on September 29, 2029, will be...

This federal Project Grant award, valued at $1,339,480.00 and awarded on September 30, 2024, was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to develop and evaluate the efficacy of a novel, patient-centered physical therapy intervention called SPINEPASS for the treatment of persistent headache following mild traumatic brain injury. The key objectives are to: Establish the efficacy of...

This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a non-profit...